Title: HIV.IND.92 Logic Id: HIVIND92Logic Version: 0.4.4 Url: HIV.IND.92 Logic Status: draft Experimental: true Type: system: http://terminology.hl7.org/CodeSystem/library-type code: logic-library Date: 2025-12-10 09:22:27+0000 Publisher: WHO Description: % of people living with HIV and co-infected with HCV who were confirmed to be cured of HCV during the reporting period Related Artifacts: Dependencies http://smart.who.int/hiv/Library/HIVCommon|0.0.1 WHOCommon HIVElements HIVIndicatorElements HIVConfig Parameters: Name Type Min Max In/Out Measurement Period Period 0 1 In Patient Patient 0 1 Out Initial Population boolean 0 1 Out Numerator boolean 0 1 Out Denominator boolean 0 1 Out Administrative Gender Stratifier Coding 0 1 Out Age Stratifier string 0 1 Out Geographic Region Stratifier string 0 1 Out patientGroups Stratifier string 0 * Out By HCV medicine type Stratifier Coding 0 1 Out Stratification string 0 1 Out Content: text/cql /** * Library: HIV.IND.92 Logic * Ref No: HEP.7 * Short Name: HCV cured among people living with HIV * * Definition: % of people living with HIV and co-infected with HCV who were confirmed to be cured of HCV during the reporting period * * Numerator: Number of people living with HIV diagnosed with HCV infection who have completed HCV treatment and had a sustained virological response (SVR). SVR is assessed by a viral load measurement 12–24 weeks after the end of treatment. * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' with "HCV treatment completion date" in the reporting period AND with "HCV viral load test date" is BETWEEN '12, 24' weeks after "HCV treatment completion date" AND "HCV viral load test result"='Not detected' * Numerator Exclusions: * * Denominator: Number of people living with HIV and co-infected with HCV who completed HCV treatment and were assessed for sustained virological response * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' with "HCV treatment completion date" in the reporting period AND with "HCV viral load test date" is BETWEEN '12, 24' weeks after "HCV treatment completion date" * Denominator Exclusions: * * Disaggregations: * • Gender (female, male, other*) * • Age (15–19, 20–24, 25–29, 30–49, 50+ years) * • Key populations (men who have sex with men, people living in prisons and other closed settings, people who inject drugs, sex workers, trans and gender diverse people)** * • Cities and other administrative regions of epidemiologic importance * • Medicine type (interferon or direct acting antivirals) * * Disaggregation Elements: Gender | Age | Key population member type | HCV medicine type * * Numerator and Denominator Elements: * HCV treatment completion date * HCV viral load test date * HCV viral load test result * HIV status * * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022 * * Data Concepts: * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth * HIV.A.DE18: Gender* | Gender of the client* * HIV.A.DE19: Female | Client identifies as female * HIV.A.DE20: Male | Client identifies as male * HIV.A.DE21: Transgender male | Client identifies as transgender male * HIV.A.DE22: Transgender female | Client identifies as transgender female * HIV.A.DE23: Other | Additional category * HIV.B.DE50: Key population member type* | The type of key population that the client is included in * HIV.B.DE51: Sex worker | Client is a sex worker * HIV.B.DE52: Men who have sex with men | Client is a man who has sex with men * HIV.B.DE53: Trans and gender-diverse people | Client identifies as trans and gender-diverse * HIV.B.DE54: People who inject drugs | Client is a person who injects drugs * HIV.B.DE55: People living in prisons and other closed settings | Client lives in a prison or another closed setting * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis. * HIV.B.DE116: HIV-positive | Client is HIV-positive * HIV.B.DE117: HIV-negative | Client is HIV-negative * HIV.B.DE118: Unknown | Client has unknown HIV status * HIV.D.DE176: HCV treatment completion date | Date when client completed treatment for hepatitis C virus (HCV) * HIV.D.DE178: HCV viral load test date | Hepatitis C viral load test date * HIV.D.DE179: HCV viral load test result | Hepatitis C viral load test result (qualitative) * HIV.D.DE180: Detected | HCV was detected * HIV.D.DE181: Not detected | HCV was not detected * HIV.D.DE182: HCV medicine type | Type of medicine client is prescribed * HIV.D.DE183: Interferon | Client is prescribed interferon * HIV.D.DE184: Direct acting antivirals | Client is prescribed direct acting antivirals * HIV.E.DE114: Key population member type* | The type of key population that the infant's mother is included in * HIV.E.DE115: Sex worker | Infant's mother is a sex worker * HIV.E.DE116: People who inject drugs | Infant's mother is a person who injects drugs * HIV.E.DE117: Trans and gender-diverse people | Infant's mother identifies as trans and gender-diverse * HIV.E.DE118: People living in prisons and other closed setting | Infant's mother is in a prison or closed setting * HIV.G.DE47: HCV viral load test date | Hepatitis C viral load test date * HIV.G.DE48: HCV viral load test result | Hepatitis C viral load test result (qualitative) * HIV.G.DE49: Detected | HCV was detected * HIV.G.DE50: Not detected | HCV was not detected * * Additional Context * - what it measures: Measures how many are cured among all those who completed treatment. * - rationale: Short courses of HCV treatment with direct acting antivirals (DAAs) lead to cure in >90% of patients and reduce mortality. Information on sustained viral response (cure) for HCV will measure treatment effectiveness and provide an incentive system, for example, cure certificates. * - method: Programme records, cohort studies, patient monitoring tools (electronic or paper), EMR/ electronic information systems, combined with best estimates for the population with no viral load data * * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm */ /* * Profiles: * - HivStatus * - HcvTreatment * - HcvViralLoadResult */ library HIVIND92Logic // Included Libraries using FHIR version '4.0.1' include HIVCommon version '0.0.1' called HIC include FHIRHelpers version '4.0.1' include WHOCommon called WCom include HIVElements called HE include HIVIndicatorElements called HIE include HIVConfig called Config // Indicator Definition parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30] context Patient /* Populations */ /* *Initial Population */ define "Initial Population": true /** * Numerator * * Definition: Number of people living with HIV diagnosed with HCV infection who have completed HCV treatment and had a sustained virological response (SVR). SVR is assessed by a viral load measurement 12–24 weeks after the end of treatment. * Calculation: COUNT of clients with "HIV status"='HIV-positive' with "HCV treatment completion date" in the reporting period AND with "HCV viral load test date" is BETWEEN '12, 24' weeks after "HCV treatment completion date" AND "HCV viral load test result"='Not detected' */ define "Numerator": HIE."Has HIV-positive Status" and HIE."HCV treatment completion date" and exists( HE."Not detected D.DE181" O with HE."HCV viral load test date D.DE178" P such that O.partOf.references(P) and (weeks between end of P.performed.toInterval() and date from end of Last(HE."HCV treatment completion date").effective.toInterval()> 12 weeks) and (weeks between end of P.performed.toInterval() and date from end of Last(HE."HCV treatment completion date").effective.toInterval()< 24 weeks) ) /** * Denominator * * Definition: Number of people living with HIV and co-infected with HCV who completed HCV treatment and were assessed for sustained virological response * Calculation: COUNT of clients with "HIV status"='HIV-positive' with "HCV treatment completion date" in the reporting period AND with "HCV viral load test date" is BETWEEN '12, 24' weeks after "HCV treatment completion date" */ define "Denominator": HIE."Has HIV-positive Status" and HIE."HCV treatment completion date" and exists(HE."HCV viral load test date D.DE178" P where (weeks between end of P.performed.toInterval() and date from end of Last(HE."HCV treatment completion date").effective.toInterval()> 12 weeks) and (weeks between end of P.performed.toInterval() and date from end of Last(HE."HCV treatment completion date").effective.toInterval()< 24 weeks) ) /* end Populations */ /* * Disaggregators */ define "Administrative Gender Stratifier": HIE."By Administrative Gender Stratifier" define "Age Stratifier": HIE."By Age Stratifier 9" define "Geographic Region Stratifier": HIE."By Geographic Region Stratifier" define "patientGroups Stratifier": HIE."patientGroups" define "By HCV medicine type Stratifier": HIE."By HCV medicine type Stratifier" define "Stratification": HIE."By Administrative Gender Stratifier".code + ':' + HIE."By Age Stratifier 9" + ':' + HIE."By Geographic Region Stratifier" + Combine(HIE.patientGroups, ':') + HIE."By HCV medicine type Stratifier".code Content: application/elm+xml Encoded data (80644 characters) Content: application/elm+json Encoded data (145528 characters)
% of people living with HIV and co-infected with HCV who were confirmed to be cured of HCV during the reporting period